Skip to main content
Clinical Trials/NCT07764081
NCT07764081RecruitingNot Applicable

Progression, Management Strategies, and Risk Factors of Coronary Artery Aneurysms: A Multicenter, Retrospective Cohort Study

Nanjing First Hospital, Nanjing Medical University1 site in 1 country1,000 target enrollmentStarted: July 31, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
1,000
Locations
1
Primary Endpoint
Progression of coronary artery aneurysm

Study Overview

Brief Summary

This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies

Detailed Description

This study aim to investigated the progression of coronary artery aneurysms (CAA) assessed by angiography, then compared the effectiveness of different management strategies, and identified risk factors associated with lesion progression and major adverse cardiovascular events.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Angiographically confirmed coronary artery aneurysm, defined as coronary dilation ≥1.5 times the adjacent normal reference vessel diameter.
  • •Age 18-80 years.

Exclusion Criteria

  • •Suboptimal image quality
  • •Incomplete clinical data, including medical history, laboratory parameters, or follow-up records.

Arms & Interventions

Coronary Artery Aneurysms

Patients with angiographically confirmed coronary artery aneurysms, defined as coronary dilation ≥1.5 times than the adjacent reference vessel diameter,

Outcomes

Primary Outcomes

Progression of coronary artery aneurysm

Time Frame: 6-12 months

Progression of coronary artery aneurysm assessed by serial angiography or coronary computed tomography angiography

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ye-fei

chief physician

Nanjing First Hospital, Nanjing Medical University

Study Sites (1)

Loading locations...

Similar Trials